Clinical Trials in San Antonio

Showing 3321-3340 of 12,572 trials

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

NCT04521413

The purpose of this study is to test the safety of an investigational drug called CFI-402411 alone and in combination with pembrolizumab and to study its effects in patients with advanced solid tumors who have progressed following previous therapies.

Advanced Solid Malignancies

Treadwell Therapeutics, Inc170 participantsStarted Aug 2020

La Jolla, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +10 more locations

TERMINATEDPhase 2< 1 mile

A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease

NCT06531395

Primary objective of the study is to evaluate the effect of abiprubart on an established systemic disease activity measure for Sjögren's Disease.

Sjögrens Disease

Kiniksa Pharmaceuticals International, plc3 participantsStarted Jul 2024

Menifee, California, United States • Poway, California, United States • Whittier, California, United States +13 more locations

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease

Find Trials by Condition in San Antonio

SURPASS Impella 5.5 Study

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)